Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BRIX1P1 is a processed pseudogene related to the BRIX1 gene, which encodes a ribosome biogenesis protein involved in ribosomal large subunit assembly. BRIX1P1 itself is not a protein-coding gene and has no established biological or therapeutic function. It is a processed pseudogene of the BRIX1 (biogenesis of ribosomes BRX1) gene. While the parent gene BRIX1 codes for a protein required for ribosomal 60S subunit biogenesis and is involved in RNA binding and ribosome assembly, BRIX1P1 itself does not encode a functional protein and lacks known biological activity, disease association, or role as a drug target. BRIX1P1 should not be considered a therapeutic target; it is not an enzyme, receptor, transporter, or transcription factor, and there is no evidence for its involvement in human diseases or response to drugs. The presence of “BRIX1P1” in a target list is likely incorrect unless explicitly intended to reference a pseudogene for research or genomic annotation purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BRIX1 pseudogene 1 (BRIX1P1).